Host Genetic, Environmental Factors Influence Urinary Tract Microbiome
By LabMedica International staff writers Posted on 14 Aug 2020 |
Graphic representation of how the urinary tract microbiome in older women exhibits host genetic and environmental influences (Photo courtesy of King\'s College London).
The urinary microbiome is a relatively unexplored niche that varies with gender. Urinary microbes, especially in aging populations, are associated with morbidity. Both genetic and environmental factors influence the makeup of the urinary tract microbiome of older women.
The term “urine microbiome” is being proposed as a term denouncing the old paradigm, that urine in the bladder is usually sterile. The bacterial species include lactobacilli, obligate anaerobes, Gardnerella vaginalis, non-hemolytic streptococci, Mycoplasma and Ureaplasma amongst others.
Medical Scientists from King's College London (London, UK) carried out a large-scale study exploring factors defining urinary microbiome composition in community-dwelling older adult women without clinically active infection. Using 1,600 twins, they estimated the contribution of genetic and environmental factors to microbiome variation.
The investigators performed 16S rRNA sequencing of midstream urine samples from the mostly post-menopausal women from the TwinsUK cohort. When they compared the composition of these samples to the previously published microbiomes of other body sites, they found the diversity of the urine dataset to be similar to that of the vaginal dataset, but that it was not as diverse as the stool dataset. Within the urinary tract microbiome, they identified a set of 61 core microbial taxa. As compared to the gut microbiome dataset, the urinary tract microbiome included more Actinobacteria, Fusobacteria, and Proteobacteria, but fewer Bacteroidetes, Firmicutes, and Verrumicrobia. For a subset of participants, they also generated shotgun metagenomic data in addition to the 16S data. The core microbiome they identified through the 16S data was largely recapitulated in the metagenomic dataset.
By using three different measurements, heritability, family segregation, and ancestry-based analyses, they found a significant effect of host genetics on the composition of the urine microbiome. In particular, for the core microbiome, they found that nearly a quarter of those variants that were found in at least 5% of participants had heritability estimates larger than 10%. One of these, Escherichia-Shigella, has been implicated in urinary tract infections and suggests host genetics may contribute to such infections.
The authors concluded that the urinary microbiome was distinct and apparently unrelated to stool microbiome. It shows a significant contribution of host genetics. Key species known to be clinically relevant were among the most heritable microbes. The study was published on July 21, 2020 in the journal Cell Host & Microbe.
Related Links:
King's College London
The term “urine microbiome” is being proposed as a term denouncing the old paradigm, that urine in the bladder is usually sterile. The bacterial species include lactobacilli, obligate anaerobes, Gardnerella vaginalis, non-hemolytic streptococci, Mycoplasma and Ureaplasma amongst others.
Medical Scientists from King's College London (London, UK) carried out a large-scale study exploring factors defining urinary microbiome composition in community-dwelling older adult women without clinically active infection. Using 1,600 twins, they estimated the contribution of genetic and environmental factors to microbiome variation.
The investigators performed 16S rRNA sequencing of midstream urine samples from the mostly post-menopausal women from the TwinsUK cohort. When they compared the composition of these samples to the previously published microbiomes of other body sites, they found the diversity of the urine dataset to be similar to that of the vaginal dataset, but that it was not as diverse as the stool dataset. Within the urinary tract microbiome, they identified a set of 61 core microbial taxa. As compared to the gut microbiome dataset, the urinary tract microbiome included more Actinobacteria, Fusobacteria, and Proteobacteria, but fewer Bacteroidetes, Firmicutes, and Verrumicrobia. For a subset of participants, they also generated shotgun metagenomic data in addition to the 16S data. The core microbiome they identified through the 16S data was largely recapitulated in the metagenomic dataset.
By using three different measurements, heritability, family segregation, and ancestry-based analyses, they found a significant effect of host genetics on the composition of the urine microbiome. In particular, for the core microbiome, they found that nearly a quarter of those variants that were found in at least 5% of participants had heritability estimates larger than 10%. One of these, Escherichia-Shigella, has been implicated in urinary tract infections and suggests host genetics may contribute to such infections.
The authors concluded that the urinary microbiome was distinct and apparently unrelated to stool microbiome. It shows a significant contribution of host genetics. Key species known to be clinically relevant were among the most heritable microbes. The study was published on July 21, 2020 in the journal Cell Host & Microbe.
Related Links:
King's College London
Latest Microbiology News
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA